Prosecution Insights
Last updated: April 19, 2026

Nevrivy Patent Law Group P.L.L.C.

18 pending office actions • 16 clients

Portfolio Summary

18
Total Pending OAs
5
Final Rejections
13
Non-Final OAs

Client Portfolio (16 clients)

Client (Assignee)Pending OAs
UNIVERSITY OF MARYLAND, BALTIMORE 2
Pleiogenix Inc. 1
Ascletis Pharma (China) Co., Limited 1
Pipeway Engenharia Ltda 1
Oxford University Innovation Limited 1
Imperial College Innovations Limited 1
The Penn State Research Foundation 1
National Research Council Of Canada 1
The United States Department of Health and Human Services 1
UNIVERSITY OF MARYLAND, BALTIMORE 1
VIRAVAXX AG 1
Imagilin Technology LLC 1
Technische Universitaet Wien 1
Los Angeles Biomedical Research Institute AT Harbor AT Ucla Medical Center 1
Yeda Research And Development Co. Ltd. 1
UNIVERSITY OF MARYLAND, BALTIMORE 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
19382043 Untitled Pleiogenix Inc. ANDERSON, JAMES D 1629 Non-Final OA
19271557 GLP-1R Agonist and Therapeutic Method Thereof Ascletis Pharma (China) Co., Limited RAHMANI, NILOOFAR 1691 Non-Final OA Jul 16, 2025
18691382 INTERNAL DUCT INTEGRITY INSPECTION EQUIPMENT USING MAGNETIC METAL MEMORY Pipeway Engenharia Ltda MORELLO, JEAN F 2855 Non-Final OA Mar 12, 2024
18287294 ON DEMAND FEMALE CONTRACEPTIVE Unknown HEASLEY, MEGHAN CHRISTINE 1626 Non-Final OA Oct 18, 2023
18451671 DETECTION OF ACUTE MYELOID LEUKAEMIA Oxford University Innovation Limited CHATTIN, AMY MARIE 1643 Non-Final OA Aug 17, 2023
18276956 GLIOMA THERAPY Imperial College Innovations Limited CHEU, CHANGHWA J 1678 Non-Final OA Aug 11, 2023
18332359 A MULTIPLEX CRISPR BASED ASSAY FOR THE SIMULTANEOUS DETECTION OF CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE The Penn State Research Foundation SCHLOOP, ALLISON ELIZABETH 1683 Non-Final OA Jun 09, 2023
17909423 LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS PROTEIN ANTIGENS AND METHODS OF USE THEREOF National Research Council Of Canada DEVI, SARVAMANGALA 1645 Non-Final OA Sep 05, 2022
17778536 BROADLY NEUTRALIZING AND POTENT ANTIBODIES AGAINST HIV The United States Department of Health and Human Services XIAO, YAN 1642 Non-Final OA May 20, 2022
17767783 COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO CELLS UNIVERSITY OF MARYLAND, BALTIMORE PURDY, KYLE A 1611 Non-Final OA Apr 08, 2022
17616584 ADJUVANTS FOR IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF UNIVERSITY OF MARYLAND, BALTIMORE HIBSHMAN, SARAH GRACE 1693 Non-Final OA Dec 03, 2021
17403846 Fusion Protein VIRAVAXX AG DESAI, ANAND U 1655 Final Rejection Aug 16, 2021
17172860 COMPOSITIONS COMPRISING PROBIOTICS AND METHODS OF USE THEREOF Imagilin Technology LLC BREEN, KIMBERLY CATHERINE 1657 Final Rejection Feb 10, 2021
17261023 MICROFLUIDIC DEVICE FOR APPLYING PRESSURE TO A CELL ASSEMBLY Technische Universitaet Wien KWAK, DEAN P 1798 Final Rejection Jan 17, 2021
17255570 METHODS OF TREATING OR PREVENTING MUCORMYCOSIS Los Angeles Biomedical Research Institute AT Harbor AT Ucla Medical Center CHEONG, CHEOM-GIL 1645 Non-Final OA Dec 23, 2020
16331863 THERMOSTABLE VARIANTS OF P. FALCIPARUM PFRH5 WHICH CAN BE PRODUCED IN BACTERIAL CELLS Yeda Research And Development Co. Ltd. ZEMAN, ROBERT A 1645 Non-Final OA Mar 08, 2019
15489658 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES UNIVERSITY OF MARYLAND, BALTIMORE MINCHELLA, KAITLYN L 1685 Final Rejection Apr 17, 2017
15028253 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES UNIVERSITY OF MARYLAND, BALTIMORE MINCHELLA, KAITLYN L 1685 Final Rejection Apr 08, 2016

Managing Nevrivy Patent Law Group P.L.L.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month